ILSI North America holds first public food packaging conference; several FDA speakers shared updates from ongoing work in pre- and post-market FCM risk assessment
FDA guidance for infant food FCMs
U.S. Food and Drug Administration releases guidance for preparation of food contact notifications for substances in contact with formula or milk
Opinion: FDA study on BPA receives unjustified criticism
Forbes reports on FDA publication finding BPA safe and opposes subsequent Mother Jones article arguing that FDA study borders on scientific misconduct
Petition urges US FDA to ban lead in FCMs
Formal petition requests revision of US Food and Drug Administration (FDA) lead standards, calls for banning lead in all FCMs; argues simple measures could significantly decrease lead level exposure from food
US FDA to review safety of BPA in food contact
US Food and Drug Administration (FDA) agrees to review the safety of bisphenol A (BPA) for use in food packaging; agency is responding to a petition filed by US civil society organizations after the European Food Safety Authority lowered official tolerable daily intake level of BPA by 100,000-fold
Update: FDA’s inaction on perchlorate
NGO highlights U.S. Food and Drug Administration’s failure to investigate sources of increased perchlorate levels in food; no response yet to NGO objection to continued use of perchlorate in food packaging
FDA guidance on forming GRAS panels
U.S. Food and Drug Administration issues draft guidance for industry with recommendations for choosing experts to make GRAS determinations; comments can be submitted until January 16, 2018 and May 15, 2018
Opinion: FDA ‘rushing to judgement’ on BPA
Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards
Final rule on GRAS
U.S. Food and Drug Administration issues final rule on food ingredients ‘generally recognized as safe’; specifies requirements for scientific evidence; notification remains voluntary
FDA roadmap for predictive toxicology
U.S. FDA publishes roadmap to further develop predictive toxicology methods for risk assessment; public workshop to be held